Detalles de la búsqueda
1.
Immune Response Persistence and Safety of a Booster Dose of the Tetravalent Dengue Vaccine in Adolescents and Adults Who Previously Completed the 3-dose Schedule 4-5 Years Earlier in Latin America: A Randomized Placebo-controlled Trial.
Pediatr Infect Dis J
; 39(10): 961-968, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32932330
Resultados
1 -
1
de 1
1
Próxima >
>>